Mental Health
FDA Authorizes Generic Lurasidone Hydrochloride Tablets
FDA Authorizes Generic Lurasidone Hydrochloride Tablets
The FDA has approved marketing of Lupin Pharmaceuticals’ Lurasidone Hydrochloride Tablets, a generic version of Sunovion Pharmaceuticals, Inc's lurasidone HCl (Latuda) tablets.
Read More >>
Preventing Unnecessary Antipsychotic Use in Patients With Dementia
Brown Bag Consult: A Patient with Parkinson's Disease and Depression
Omega-3 Reduces Chronic Inflammation, Improves Blood Flow to Combat Depression
Michael Lewis, MD Discusses Low Omega-3 and Suicide Risk
FDA Panels Vote Against Recommending MDD Drug, ALKS 5461
Arthritis Prevalent with Depressive Symptoms in Older Adults
National Mental Illness Awareness Week Addresses Stigmas
View more articles >>
Clinical Trials
Lithium Therapeutic Drug Monitoring; Once Daily Vs Twice Daily Dosing and the Impact of Kidney Function
Extension Study Evaluating The Safety And Tolerability Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolar I Disorder
The Role of Sex Steroids and Serotonin Brain Dynamics in Perinatal Mental Health
Toward Exercise as Medicine for Adolescents With Bipolar Disorder
Augmenting Hospitalization for Serious Mental Illness: Cognitive Bias Modification
Multimedia: Videos
Depression and Burnout
Depression and Burnout
Omega-3 Reduces Chronic Inflammation, Improves Blood Flow to Combat Depression
Omega-3 Reduces Chronic Inflammation, Improves Blood Flow to Combat Depression
Michael Lewis, MD Discusses Low Omega-3 and Suicide Risk
Michael Lewis, MD Discusses Low Omega-3 and Suicide Risk
Best Practices for an Alternative Site of Care
Best Practices for an Alternative Site of Care